Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Keros Therapeutics Inc
(NQ:
KROS
)
53.88
+1.37 (+2.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
344,624
Open
52.54
Bid (Size)
50.17 (1)
Ask (Size)
57.46 (1)
Prev. Close
52.51
Today's Range
52.54 - 55.25
52wk Range
27.02 - 73.00
Shares Outstanding
23,337,862
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Keros Therapeutics Stock Meets 80-Plus RS Rating Benchmark
September 05, 2024
Building your watch list, look for stocks with an 80-plus RS Rating. Keros Therapeutics stock just met that criteria with a new score of 86.
Via
Investor's Business Daily
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 03, 2024
Via
Benzinga
Performance
YTD
+24.92%
+24.92%
1 Month
+20.16%
+20.16%
3 Month
+10.27%
+10.27%
6 Month
-18.75%
-18.75%
1 Year
+47.58%
+47.58%
More News
Read More
Vaxcyte, Shoals Technologies, Polestar Automotive, Applied Optoelectronics And Other Big Stocks Moving Higher On Tuesday
September 03, 2024
Via
Benzinga
Keros Therapeutics Inc. (NASDAQ: KROS) Near the Top of Equities by Percentage Gain on 1/4
January 04, 2024
Via
Investor Brand Network
Where Keros Therapeutics Stands With Analysts
July 26, 2023
Via
Benzinga
KROS Stock Earnings: Keros Therapeutics Misses EPS for Q2 2024
August 07, 2024
Via
InvestorPlace
Analyst Sees Keros Therapeutics As Next Acceleron, Set For Major Biotech Growth
June 25, 2024
Via
Benzinga
KROS Stock Earnings: Keros Therapeutics Beats EPS for Q1 2024
May 08, 2024
Via
InvestorPlace
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 04, 2024
Via
Benzinga
Recap: Keros Therapeutics Q1 Earnings
May 04, 2023
Via
Benzinga
Recap: Keros Therapeutics Q3 Earnings
November 03, 2022
Via
Benzinga
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday
January 04, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 11, 2023
Via
Benzinga
Coinbase, Riot Platforms, Marathon Digital And Other Big Stocks Moving Lower On Monday
December 11, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
July 31, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2023
July 26, 2023
Via
Benzinga
Why American Software Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 09, 2023
Via
Benzinga
Why Shares of Keros Therapeutics Jumped This Week
April 21, 2023
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2023
February 14, 2023
Via
Benzinga
BioMedNewsBreaks – Keros Therapeutics Inc. (NASDAQ: KROS) Presents Clinical and Preclinical Data from Its Lead Hematological Programs at 64th ASH Event
December 13, 2022
Via
Investor Brand Network
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
October 18, 2022
Via
Benzinga
Why Shares of Keros Therapeutics Rose 10.2% This Week
October 14, 2022
Via
The Motley Fool
Alphatec Holdings, Immatics And Some Other Big Stocks Moving Higher On Monday
October 10, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022
July 26, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 23, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.